Success Metrics

Clinical Success Rate
82.6%

Based on 19 completed trials

Completion Rate
83%(19/23)
Active Trials
8(20%)
Results Posted
47%(9 trials)
Terminated
4(10%)

Phase Distribution

Ph phase_3
8
20%
Ph not_applicable
7
18%
Ph phase_2
5
13%
Ph early_phase_1
3
8%
Ph phase_4
11
28%
Ph phase_1
4
10%

Phase Distribution

7

Early Stage

5

Mid Stage

19

Late Stage

Phase Distribution38 total trials
Early Phase 1First-in-human
3(7.9%)
Phase 1Safety & dosage
4(10.5%)
Phase 2Efficacy & side effects
5(13.2%)
Phase 3Large-scale testing
8(21.1%)
Phase 4Post-market surveillance
11(28.9%)
N/ANon-phased studies
7(18.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.4%

19 of 27 finished

Non-Completion Rate

29.6%

8 ended early

Currently Active

8

trials recruiting

Total Trials

40

all time

Status Distribution
Active(9)
Completed(19)
Terminated(8)
Other(4)

Detailed Status

Completed19
Recruiting7
Withdrawn4
Terminated4
unknown3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
40
Active
8
Success Rate
82.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (7.9%)
Phase 14 (10.5%)
Phase 25 (13.2%)
Phase 38 (21.1%)
Phase 411 (28.9%)
N/A7 (18.4%)

Trials by Status

withdrawn410%
completed1948%
terminated410%
not_yet_recruiting13%
active_not_recruiting13%
unknown38%
recruiting718%
suspended13%

Recent Activity

Clinical Trials (40)

Showing 20 of 40 trialsScroll for more
NCT05085808Phase 4

RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ)

Withdrawn
NCT05307003

Trazodone vs. Quetiapine for the Treatment of ICU Delirium

Terminated
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT03668041Phase 3

National Adaptive Trial for PTSD Related Insomnia

Completed
NCT07136415Phase 4

Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms

Recruiting
NCT05209035Phase 4

Evaluation of Trazodone in OSA-MCI

Active Not Recruiting
NCT02922894Phase 4

Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury

Recruiting
NCT06281756Early Phase 1

Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia

Recruiting
NCT05282550Phase 2

Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone

Recruiting
NCT05299398Phase 1

Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone

Withdrawn
NCT04468776Phase 4

CBT-I or Zolpidem/Trazodone for Insomnia

Completed
NCT05125146Not Applicable

Investigating the Effectiveness of E-CBTi Compared to Pharmaceutical Interventions in Treating Insomnia

Recruiting
NCT06546358Early Phase 1

Quetiapine Versus Trazadone in Women With Postpartum Depression

Not Yet Recruiting
NCT05293600Phase 1

Rescue Pharmacotherapy for OSA

Recruiting
NCT03534284Phase 3

Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis

Completed
NCT04082806Phase 2

Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.

Completed
NCT02655354Not Applicable

A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity

Completed
NCT02458469Phase 2

Role of Enhancing Serotonin Receptors Activity for Sleep Apnea Treatment in Patients With SCI

Completed
NCT01651442Not Applicable

Sequenced Therapies for Comorbid and Primary Insomnias

Completed
NCT02945644Phase 1

Trazodone Dose Tolerance and APAP Adherence

Suspended

Drug Details

Intervention Type
DRUG
Total Trials
40